Skip to main content
BIOMERICA INC logo

BIOMERICA INC — Investor Relations & Filings

Ticker · BMRA ISIN · US09061H3075 US Manufacturing
Open in API
Filings indexed 587 across all filing types
Latest filing 2022-08-29 Annual Report
Country US United States of America
Listing US BMRA

About BIOMERICA INC

https://biomerica.com/

Biomerica, Inc. is a global biomedical technology company that develops, patents, manufactures, and markets advanced in-vitro diagnostic (IVD) and therapeutic products. The company provides solutions for both laboratory and at-home testing, designed for the early detection and monitoring of chronic conditions. Its primary research and development focus is on gastrointestinal and inflammatory diseases, with a notable pipeline that includes a non-drug, diagnostic-guided therapy for Irritable Bowel Syndrome (IBS). Biomerica's products aim to enhance patient health and well-being while contributing to the reduction of total healthcare costs.

Recent filings

Filing Released Lang Actions
FORM 10-K
Annual Report FY 2022
2022-08-29 English
PRIMARY DOCUMENT
Director's Dealing
2022-06-24 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, specifically reporting a change in the company's independent registered public accounting firm. It details the dismissal of the previous auditor and the engagement of a new auditor, including disclosures about audit opinions and disagreements. This type of filing is an announcement related to changes in auditors, which is typically classified under Regulatory Filings (RNS) as it does not constitute a full audit report or annual report but is a regulatory disclosure about auditor changes. The document length is 5779 characters, which is sufficient for a detailed announcement but does not contain full financial statements or audit reports themselves. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-04-19 English
FORM 10-Q
Interim / Quarterly Report 9M 2022
2022-04-14 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-14 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes a press release about clinical trial results and plans to meet with the FDA, but it does not contain financial statements or detailed financial analysis. The document is not an annual or quarterly report, nor is it an earnings release or management discussion. It is primarily a regulatory announcement of a significant event (clinical trial results) and includes a press release as an exhibit. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-02-10 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.